Present investigation present docking studies on 4-(4-butyl-3-(cyclohexyl(hydroxyl)methyl-2,5-dioxo-1,4,9-triazaspiro[5,5]undecan-9-yl)methyl)phenoxy)benzoic acid emerged as noval antiretroviral drug candidate. Docking studies reveals that said drug candidate bind to CCR5 polypeptide protein by hydrogen bonding. In addition, existence of spiro centre played crucial role in drug peptide interaction.
Loading....